Ginsenoside Rg1 exerts anti‑apoptotic effects on non‑alcoholic fatty liver cells by downregulating the expression of SGPL1-Reference-Cited by-同舟云学术

Ginsenoside Rg1 exerts anti‑apoptotic effects on non‑alcoholic fatty liver cells by downregulating the expression of SGPL1

Published:2022-03-22 Issue:5 Volume:25 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Li Guiming¹,Xie Hongqing¹,Cao Xiaodie²,Ma Chong²,Li Yan¹,Chen Li¹

Affiliation:

1. Department of Geriatrics, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650100, P.R. China

2. Department of Pathophysiology, Medical School, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference41 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the american association for the study of liver diseases;Chalasani;Hepatology,2018

2. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012;Nishioji;J Gastroenterol,2015

3. Modeling nafld disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, And United States for the period 2016–2030;Estes;J Hepatol,2018

4. Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies;Li;J Gastroenterol Hepatol,2014

5. Investigating fibrosis and inflammation in an ex vivo NASH murine model;Gore;Am J Physiol Gastrointest Liver Physiol,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic Hepatocytes;Small;2024-07

2. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation;EPMA Journal;2024-04-18

3. Probable targets and mechanism of ginsenoside Rg1 for non-alcoholic fatty liver disease: a study integrating network pharmacology, molecular docking, and molecular dynamics simulation;Journal of Biomolecular Structure and Dynamics;2023-12

4. Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Journal of Ginseng Research;2023-11

5. Quality Markers’ Discovery and Quality Evaluation of Jigucao Capsule Using UPLC-MS/MS Method;Molecules;2023-03-08